Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2021.
Financials
Financial year 2024
EUROPHARMA GROUP from Tongeren-Borgloon, company number BE0811185660, closed financial year 2024 with a result of € 72,635 after tax. For that financial year EUROPHARMA GROUP recorded a gross margin of € 277,446 and equity of € 326,697. Compared with financial year 2023, the result moved from € 69,783 to € 72,635. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.
€ 326,697
▲ 29% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 72,635
▲ 4% vs 2023
Profit after tax over the fiscal year.
€ 11,243
▲ € 9,000 vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 316,697.
People and assets in 2024
€ 94,963
▼ 20% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 45,843
▼ 40% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 222,458
▼ 11% vs 2023
€ 85,215 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 183,082
Supplier invoices still open on the last day of the fiscal year.
€ 74,519
▲ 4% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 127,534 | € 281,172 | € 283,498 | € 277,446 | ▼ 2% |
| Profit after taxes | € 31,513 | € 101,709 | € 69,783 | € 72,635 | ▲ 4% |
| Equity | € 132,570 | € 234,280 | € 254,062 | € 326,697 | ▲ 29% |
| Total debts | € 426,230 | € 436,370 | € 504,183 | € 480,059 | ▼ 5% |
| Cash | € 1,472 | € 25,316 | € 2,243 | € 11,243 | ▲ € 9,000 |
| Land & buildings | € 225,477 | € 201,126 | € 176,775 | € 152,425 | ▼ 14% |
| Retained profit | € 122,570 | € 224,280 | € 244,062 | € 316,697 | ▲ 30% |
| Dividend | € 0 | € 0 | € 50,000 | € 0 | ▼ 100% |
| Bank debt | € 301,734 | € 237,045 | € 249,139 | € 222,458 | ▼ 11% |
| Balance sheet total | € 558,800 | € 670,650 | € 758,245 | € 806,756 | ▲ 6% |
Key figures of EUROPHARMA GROUP, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to EUROPHARMA GROUP?
What happened at EUROPHARMA GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 72,635 (▲ 4% vs 2023). filed late Source: NBB ↗
- New establishment in Tongeren-Borgloon. KBO
- Start of the company according to the CBE. KBO
In short
From € 31,513 profit in 2021 to € 72,635 profit in 2024.
Paid € 115,737 in corporate taxes since 2021.
Best year ever: 2022, with € 101,709 profit.
Paid out € 50,000 in dividends to the owners in total.
A new publication or filing at EUROPHARMA GROUP? We notify you, reason included.
Follow EUROPHARMA GROUPDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind EUROPHARMA GROUP is Sebastiano DULIEU. Sebastiano DULIEU is also behind IMPERO VINI.
Directors
According to the 2024 annual accounts
Establishments
Establishment units
Physical locations of this company
Heersterveldweg 16A box 9
3700 Tongeren-Borgloon
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.
All companies at this address →JK Technieken
€ 101,340 gross margin · 2024
JPConcept
€ -52 gross margin · 2025
DIGITONG
€ 745,380 gross margin · 2025
AQUA-SAVING
GLOBAL UNITY
€ -24,713 gross margin · 2025
+4 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
OVH, FR
Domain
Domain
europharmagroup.com
Registered
2009-03-25
Registrar
EuroDNS S.A.
Expires
2027-03-25
Website info
Features
Security
Details
- Company number
- 0811.185.660
- VAT number
- BE 0811.185.660
- Registered office
- Heersterveldweg 16A bus 9, 3700 Tongeren-Borgloon
- Names & denominations
- EUROPHARMA GROUP
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 April 2009
- Peppol
- Active · Active since 19 Dec 2025
- Contact
- europharmagroup.com
- Activities · NACE
Groothandel in parfumerieën en cosmetica
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering